drugset / Trial / NCT03800290

Human Beta-2 Adrenergic Stimulation and Muscle Glucose Uptake

NCT03800290

Phase 2 Completed 11 enrolled Maastricht University
RandomizedCrossoverDouble-blindTreatment

Summary

The purpose of this study is to investigate the effect of two weeks clenbuterol/placebo supplementation on skeletal muscle glucose disposal in healthy male volunteers.

Timeline

Start
2019-06-01
Primary completion
2021-04-23
Completion
2021-04-23

Drugs

EvaluationDrugModalityDoseRoute
Subject Clenbuterol Small molecule 40 ug Oral

Indications

No indication recorded.